Nakagawa R, Naito R, Izumi K, Inaba T, et al. Real-World Efficacy of Postoperative Adjuvant Nivolumab in High-Risk Urothelial Carcinoma: A Retrospective Comparative Study in an Asian Population. Asia Pac J Clin Oncol 2026;22:685-691.
PMID: 41220193